LYRA Competitors & Alternatives
Compare Lyra Therapeutics Inc with similar stocks in the same industry
Biotechnology
LYRA
Main Stock$0.50
-62.50%
Tradestie Score
44
Market Cap
$10.80M
Revenue Growth
-87.2%
Analyst Upside
+3132.3%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Delivery
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.18
+0.37%
|
$154.27M | - | 54 | Compare |
|
OBIO
Orchestra BioMed Holdings, Inc. Ordinary Shares
|
$7.07
-0.70%
|
$137.59M | - | 37 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.63
-3.12%
|
$133.50M | - | 45 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$30.16
-6.68%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.11
-7.41%
|
$110.20M | - | 34 | Compare |
|
PLRX
Pliant Therapeutics, Inc. Common Stock
|
$0.67
-3.53%
|
$89.01M | - | 39 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.03
+0.17%
|
$84.52M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.20
-3.74%
|
$67.94M | - | 52 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$4.20
+1.57%
|
$25.84M | - | 20 | Compare |
|
OPNT
OPNT
|
- | - | - | - | Compare |
More LYRA Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 3841)
219 stocks in this industry